Amended Quarterly Report (10-q/a)
August 24 2020 - 01:43PM
Edgar (US Regulatory)
U.S. SECURITIES
AND EXCHANGE COMMISSION
Washington, D.
C. 20549
FORM 10-Q/A
(Mark One)
☒
|
QUARTERLY REPORT UNDER
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934
|
For the fiscal quarter
ended June 30, 2020
☐
|
TRANSITION REPORT UNDER
SECTION 13 OR 15(d) OF THE EXCHANGE ACT
|
For the transition
period from ____________to____________
MANHATTAN SCIENTIFICS, INC.
|
(Exact name of small
business issuer as specified in its charter)
|
Delaware
|
|
000-28411
|
|
85-0460639
|
(State of
Incorporation)
|
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.)
|
244 Fifth Ave,
Suite 2341
New York, New
York, 10001
(Address of principal
executive offices) (Zip code)
Issuer’s telephone
number: (212) 541-2405
Securities registered
under Section 12(b) of the Exchange Act: None
Securities registered
under Section 12(g) of the Exchange Act:
Common Stock,
$0.001 par value
(Title of Class)
Indicate by check mark
whether the registrant (1) filed all reports required to be filed
by Section 13 or 15(d) of the Exchange Act during the preceding 12
months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark
whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File
required to be submitted and posted pursuant to Rule 405 of
Regulation S-T during the preceding 12 months (or for such shorter
period that the registrant was required to submit and post such
files). Yes ☒ No ☐
Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See
definitions of “large accelerated filer,” “accelerated filer” and
“smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated
filer
|
☐
|
Accelerated filer
|
☐
|
Non-accelerated
filer
|
☒
|
Smaller reporting
company
|
☒
|
|
|
Emerging growth
company
|
☐
|
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark
whether the registrant is a shell company (as defined in Rule 12b-2
of the Exchange Act). Yes ☐ No ☒
There
were 557,781,064 shares outstanding of registrant’s common
stock, par value $0.001 per share, as of August 19, 2020.
EXPLANATORY
NOTE
This Amendment No.1 to
our Quarterly Report on Form 10-Q/A (the “10-Q/A”) amends the
Quarterly Report on Form 10-Q for the quarter ended June 30, 2020,
as originally filed with the Securities and Exchange Commission on
August 19, 2020 (the “original Form 10-Q”).
The purpose of this
Form 10-Q/A is to disclose the financials in XBRL format, which
were not disclose in the Original Form 10-Q. No additional changes,
revisions, or updates have been made to the original Form 10-Q in
this Form 10-Q/A. This Amendment No. 1 to the Form 10-Q speaks as
of the original filing date of the Form 10-Q, does not reflect
events that may have occurred subsequent to the original filing
date.
ITEM 6.
EXHIBITS
Index to
Exhibits
_________________
* Previously
filed
** XBRL (Extensible
Business Reporting Language) information is furnished and not filed
or a part of a registration statement or prospectus for purposes of
Sections 11 or 12 of the Securities Act of 1933, as amended,
is deemed not filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, and otherwise is not
subject to liability under these sections.
SIGNATURES
In accordance with
Section 13 or 15(d) of the Exchange Act, the registrant caused this
report to be signed on its behalf by the undersigned, thereunto
duly authorized on this 20th day of August, 2020.
|
MANHATTAN
SCIENTIFICS, INC.
|
|
|
|
|
|
|
By:
|
/s/ Emmanuel
Tsoupanarias
|
|
|
Name:
|
Emmanuel
Tsoupanarias
|
|
|
Title:
|
Chief Executive
Officer
(Principal Executive,
Financial and Accounting Officer)
|
|
Manhattan Scientifics (QB) (USOTC:MHTX)
Historical Stock Chart
From Dec 2020 to Jan 2021
Manhattan Scientifics (QB) (USOTC:MHTX)
Historical Stock Chart
From Jan 2020 to Jan 2021